Bruker Shares Hit 52-Week High | GenomeWeb

Shares in Bruker BioSciences briefly climbed to a 52-week high of $5.70 this week, before closing up 11.75 percent to $5.61 on Tuesday. The firm's shares rose this past week after announcing a biodefense contract for the United Arab Emirates. Molecular Devices also hovered near a 52-week high, closing up 8.89 percent for the tracking period ended Tuesday.

Harvard Bioscience led decliners for the week, closing the period down 7.39 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.